Want to see IN:MANGALAM full AI Analyst Report?
Mangalam Drugs & Organics Ltd. (MANGALAM) Financial Statements
Mangalam Drugs & Organics Ltd. Financial Overview
Mangalam Drugs & Organics Ltd.'s market cap is currently $457.75M. The company's EPS TTM is $-24.16; its P/E ratio is -1.18; and it has a dividend yield of 0.28%. Mangalam Drugs & Organics Ltd. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.32B | $ 3.18B | $ 3.67B | $ 3.70B | $ 4.47B |
| Gross Profit | $ 232.46M | $ 1.50B | $ 188.12M | $ 287.77M | $ 546.89M |
| Operating Income | $ -331.26M | $ 174.00M | $ 10.62M | $ 150.97M | $ 355.66M |
| EBITDA | $ -149.03M | $ 363.25M | $ 174.76M | $ 259.54M | $ 451.84M |
| Net Income | $ -444.00M | $ 67.21M | $ -90.72M | $ 12.70M | $ 196.57M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 7.01M | $ 25.89M | $ 11.87M | $ 26.88M | $ 19.55M |
| Total Assets | $ 3.15B | $ 3.66B | $ 3.34B | $ 3.60B | $ 3.28B |
| Total Debt | $ 1.05B | $ 962.30M | $ 1.07B | $ 885.47M | $ 879.04M |
| Net Debt | $ 1.05B | $ 936.41M | $ 1.06B | $ 858.66M | $ 859.58M |
| Total Liabilities | $ 2.12B | $ 2.17B | $ 1.98B | $ 2.08B | $ 1.78B |
| Stockholders' Equity | $ 1.03B | $ 1.49B | $ 1.36B | $ 1.52B | $ 1.51B |
| Cash Flow | |||||
| Free Cash Flow | $ -208.11M | $ 223.93M | $ -79.20M | $ 116.09M | $ -19.60M |
| Operating Cash Flow | $ -89.12M | $ 425.94M | $ 39.13M | $ 395.23M | $ 257.09M |
| Investing Cash Flow | $ -117.25M | $ -194.72M | $ -118.27M | $ -221.72M | $ -273.26M |
| Financing Cash Flow | $ 187.49M | $ -217.12M | $ 52.27M | $ -166.17M | $ 29.79M |
Currency in INR